ambossIconambossIcon

Acquired tracheoesophageal fistula

Last updated: November 25, 2025

CME information and disclosurestoggle arrow icon

To see contributor disclosures related to this article, click on this reference: [1]

Physicians can earn CME/MOC credit by using this article to address a clinical question and completing a brief evaluation about how they applied the information in their practice.

AMBOSS designates this internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For answers to questions about AMBOSS CME, including how to redeem CME/MOC credit, see “Tips and links” at the bottom of this article.

Summarytoggle arrow icon

Acquired tracheoesophageal fistula (TEF) is an abnormal connection between the trachea and esophagus caused by another condition (e.g., malignancy, trauma). Acquired TEF typically manifests with cough, dysphagia, dyspnea, and/or recurrent lung infections. Barium esophagogram and/or endoscopy confirm the diagnosis. Treatment involves a multidisciplinary team focusing on preventing aspiration, managing the underlying cause, and closing the fistula via surgery or endoscopy.

See also “Congenital tracheoesophageal fistula.”

Etiologytoggle arrow icon

Clinical featurestoggle arrow icon

Clinical features vary based on size, location, and rate of formation of the fistula. [2]

Diagnosistoggle arrow icon

Treatmenttoggle arrow icon

Treatment is guided by a multidisciplinary team, including gastroenterology, pulmonology, thoracic surgery, and oncology. [2]

Initial management [2][3][4]

Acute respiratory distress

In patients with known acquired TEF presenting with respiratory distress signs or clinical features of airway obstruction:

Aspiration prevention in acquired TEF [2][3]

Definitive management [2][3]

Spontaneous closure of acquired tracheoesophageal fistula is rare, and intervention is typically required. [3]

  • Malignant acquired TEFs: esophageal stent ± airway stent
  • Nonmalignant acquired TEFs: Management options vary by size and location and may include the following.

Complicationstoggle arrow icon

We list the most important complications. The selection is not exhaustive.

Icon of a lock3 free articles left this month

Start a 5-day free trial or sign up for unlimited access.
 Evidence-based content, created and peer-reviewed by clinicians. Read the disclaimer